| CAS ID: | 74578-69-1 |
| Molecular Formula: | C18H18N8O7S3 |
| Molecular Weight: | 554.6 g/mol |
| Monoisotopic Mass: | 554.0461 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | RO 13-9904 | Ro-13-9904 | Rocephin | CEFTRIAXONE SODIUM | CEFTRIAXONE |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C18H18N8O7S3/c1-25-18(22-12(28)13(29)23-25)36-4-6-3-34-15-9(14(30)26(15)10(6)16(31)32)21-11(27)8(24-33-2)7-5-35-17(19)20-7/h5,9,15H,3-4H2,1-2H3,(H2,19,20)(H,21,27)(H,23,29)(H,31,32)/b24-8-/t9-,15-/m1/s1 | See All |
| InChI Key: | VAAUVRVFOQPIGI-SPQHTLEESA-N | |
| Smiles: | CO\N=C(/C(=O)N[C@H]1[C@H]2SCC(=C(N2C1=O)C(=O)O)CSC3=NC(=O)C(=NN3C)O)\c4csc(N)n4 | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT01265173 | Disease | Liver fibrosis |
| Phase | Phase 4 | Status | Completed |
| First Received | December 23, 2010 | Last Verified | August 22, 2017 |
| Sponsor | Korea University | ||